Sign in Create account

Morepen Laboratories Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: MOREPENLAB BSE: 500288
₹125.99
▲ 7.19 (6.05%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
64/100
Moderate
Valuation
34/100
Fairly Valued
Momentum
55/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹6,904 Cr
PE (TTM)
61.5
Industry median 36.1 (152 companies)
Price to Book
5.5
PEG (TTM)
1.2
Institutions holding %
2.74%
FII + DII, latest filed period
Piotroski Score
5
Relative return vs Nifty50, qtr %
137.9
Relative return vs Sector, qtr %
101.0
Free Cash Flow
₹-53 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
560.00%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-26.97%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
17.36%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
68.94%
as of March 31, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
38.27%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
2.37
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.16
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
9.79
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
4.35%
as of March 31, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
14.22%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
9.13%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
4.90%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
9.43%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
7.61%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 5)
  • Yes Debt to equity is below 0.5 (0.16)
  • No Return on equity is 15% or more (7.6%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
6.1%
Low 117.8000 · High 128.1000
1W return
3.0%
Low 115.5600 · High 128.1000
1M return
17.6%
Low 97.0400 · High 128.1000
52W return
158.1%
Low 33.0500 · High 128.1000
Lifetime High ₹1066.8000 (Feb. 11, 2000)
Lifetime Low ₹2.1000 (Aug. 6, 2013)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish6
Bearish0
5D
121.7
10D
119.9
20D
115.2
50D
98.8
100D
81.3
200D
56.2

Delivery and volume

Day avg. delivery
21.6%
Week avg. delivery
27.5%
Month avg. delivery
27.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

123.96
Pivot
First resistance130.13
Second resistance134.26
Third resistance140.43
First support119.83
Second support113.66
Third support109.53
Day RSI65.9
Day MFI73.3
Day MACD7.37
Day MACD signal8.34

Beta

1M2.83
3M1.41
1Y1.55
3Y1.61

Price change analysis

↑ 17.6%
Over 1 Month
LowHigh
97.04128.10
↑ 101.0%
Over 3 Months
LowHigh
51.38128.10
↑ 238.7%
Over 6 Months
LowHigh
35.17128.10
↑ 158.1%
Over 1 Year
LowHigh
33.05128.10
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 61.5 (own history: 19.4–46.9)
Overvalued (above its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹541 Cr
Net profit (June 30, 2026)
₹54 Cr
Basic EPS (June 30, 2026)
₹0.9900

Ranks #53 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter35.65%
  • FII/FPI1.46%
  • Other DII1.28%
  • Public61.61%

Largest holders

NameCategoryShares %Shares
PINFOLD OVERSEAS LIMITEDPublic7.0300%38530000
SCOPE CREDITS AND FINANCIAL SERVICES PVT. LTD.Promoter2.8400%15575405
CONCEPT CREDITS AND CONSULTANTS PVT. LTD.Promoter2.8000%15347724
BROOK INVESTMENTS AND FINANCIAL SERVICES PVT. LTDPromoter2.7700%15159252
SOLITARY INVESTMENTS AND FINANCIAL SERVICES PVT. LTD.Promoter2.7600%15114045

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 35.65% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 1.58% to 1.46% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 24 insider trades, 5 SAST, 1 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
22 Sep 2022 Liquid Holdings Private Limited Promoter group Buy 0 ₹0
22 Sep 2022 React Investments and Financial Services Private Limited Promoter group Buy 0 ₹0
22 Sep 2022 Mid-Med Financial Services and Investments Private Limited Promoter group Buy 0 ₹0
5 Apr 2022 Seed Securities and Services Private Limited Promoter group Buy 0 ₹0
5 Apr 2022 Solitary Investments and Financial Services Private Limited Promoter group Buy 0 ₹0
5 Apr 2022 Solace Investments and Financial Services Private Limited Promoter group Buy 0 ₹0
5 Apr 2022 Scope Credits and Financial Services Private Limited Promoter group Buy 0 ₹0
5 Apr 2022 Square Investments and Financial Services Private Limited Promoter group Buy 0 ₹0
5 Apr 2022 Brook Investments and Financial Services Private Limited Promoter group Buy 0 ₹0
5 Apr 2022 Concept Credits and Consultants Private Limited Promoter group Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 115 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
16 Sep 2026 HRTI PRIVATE LIMITED Bulk Sell 2,813,508 107.1800 NSE
16 Sep 2026 HRTI PRIVATE LIMITED Bulk Buy 2,528,438 106.1200 NSE
31 Aug 2026 HRTI PRIVATE LIMITED Bulk Buy 3,176,302 105.5000 NSE
31 Aug 2026 HRTI PRIVATE LIMITED Bulk Sell 3,184,756 105.9400 NSE
20 Aug 2026 QE SECURITIES LLP Bulk Sell 2,964,621 93.3900 NSE
20 Aug 2026 QE SECURITIES LLP Bulk Buy 2,934,639 93.9100 NSE
20 Aug 2026 HRTI PRIVATE LIMITED Bulk Sell 3,104,810 93.7200 NSE
20 Aug 2026 HRTI PRIVATE LIMITED Bulk Buy 3,005,655 93.4400 NSE
17 Aug 2026 HRTI PRIVATE LIMITED Bulk Sell 4,127,672 87.2800 NSE
17 Aug 2026 HRTI PRIVATE LIMITED Bulk Buy 3,672,287 87.3100 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹0.20 per share
Dividend yield 0.16%
Ex-dateSubjectPer share (₹)Record date
— Final Dividend - Rs. - 0.2000 — —
18 Sep 2026 Dividend - Re 0.20 Per Share 0.2000 19 Sep 2026
29 Aug 2025 Dividend - Re 0.20 Per Share 0.2000 30 Aug 2025

Corporate Actions

Full history (23 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
20 Sep 2024OTHERAnnual General Meeting
21 Sep 2023OTHERAnnual General Meeting
19 Sep 2022OTHERAnnual General Meeting
20 Sep 2021OTHER Annual General Meeting
22 Sep 2020OTHER Annual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
4 Aug 2026 Financial Results/Other business matters Yes
26 May 2026 Financial Results/Dividend/Other business matters Yes
10 Feb 2026 Financial Results/Other business matters Yes
14 Nov 2025 Financial Results Yes
6 Aug 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 850 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Insider Trading / SAST Morepen Laboratories Ltd - 500288 - Closure of Trading Window
28 Sep 2026 Trading Window Morepen Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
28 Sep 2026 Press Release Morepen Laboratories Limited has informed the Exchange regarding a press release dated September 28, 2026, titled "Morepen strengthens integrated CDMO capabilities with first U.S. ANDA submission".
28 Sep 2026 Company Update Morepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
26 Sep 2026 Shareholders meeting Please find attached the Voting Results and the Scrutinizer Report of 41st Annual General Meeting
26 Sep 2026 Shareholders meeting Morepen Laboratories Limited has informed the Exchange regarding Proceedings of 41st Annual General Meeting held on September 26, 2026
22 Sep 2026 General Updates Morepen Laboratories Limited has informed the Exchange about ESG Rating.
7 Sep 2026 Company Update Morepen Laboratories Ltd - 500288 - Announcement Under Regulation 30 Of The SEBI (LODR)
7 Sep 2026 General Updates Business Update First Phase of Manufacturing Capacity Expansion Completed Ahead of Schedule
3 Sep 2026 Copy of Newspaper Publication Newspaper publication for completion of dispatch of the notice of 41st AGM and Annual report for the FY 2025-26

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.16)
  • Healthy liquidity (Current Ratio 2.37)
  • Strong revenue growth YoY (38.3%)

Weaknesses

  • Low Return on Equity (7.6%)
  • Thin net profit margin (4.3%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (61.5) -- priced for continued strong execution

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Morepen Laboratories Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.